ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,404 | -74.2% | 41,000 | 0.0% | 0.00% | – |
| Q2 2023 | $20,910 | -20.5% | 41,000 | -1.8% | 0.00% | – |
| Q1 2023 | $26,303 | -2.9% | 41,750 | 0.0% | 0.00% | – |
| Q4 2022 | $27,100 | -61.3% | 41,750 | +2.5% | 0.00% | -100.0% |
| Q3 2022 | $70,000 | +70.7% | 40,750 | +23.5% | 0.00% | – |
| Q2 2022 | $41,000 | -10.9% | 33,000 | -53.5% | 0.00% | – |
| Q1 2022 | $46,000 | -37.8% | 71,000 | +4.8% | 0.00% | -100.0% |
| Q4 2021 | $74,000 | -40.3% | 67,780 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $124,000 | +69.9% | 67,780 | +144.0% | 0.00% | 0.0% |
| Q2 2021 | $73,000 | -27.0% | 27,780 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $100,000 | +42.9% | 27,780 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $70,000 | 0.0% | 27,780 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | +677.8% | 27,780 | +1041.8% | 0.00% | – |
| Q1 2018 | $9,000 | -40.0% | 2,433 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +15.4% | 2,433 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | – | 2,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |